QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
TSE:VRX

Valeant Pharmaceuticals International - VRX Stock Forecast, Price & News

C$30.80
-1.06 (-3.33%)
(As of 07/13/2018)
Add
Compare
Today's Range
C$30.75
C$32.19
50-Day Range
C$30.80
C$30.80
52-Week Range
C$14.01
C$36.02
Volume
1.23 million shs
Average Volume
1.38 million shs
Market Capitalization
C$10.76 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

VRX stock logo

About Valeant Pharmaceuticals International (TSE:VRX) Stock

Valeant Pharmaceuticals International, Inc. operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products. The Bausch + Lomb/International segment provides pharmaceutical products, OTC products, and medical device products, primarily consist of Bausch + Lomb products, with a focus on the vision care, surgical, consumer, and ophthalmology Rx products in the United States; and pharmaceutical products, generic pharmaceutical products, OTC products, medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia and New Zealand, Latin America, Africa, and the Middle East. The Branded Rx segment sells gastrointestinal and dermatological products in the United States. The U.S. Diversified Products segment offers pharmaceutical products, OTC products, and medical device products in the areas of neurology and certain other therapeutic classes, including aesthetics. The company was founded in 1983 and is headquartered in Laval, Canada.

Receive VRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Valeant Pharmaceuticals International and its competitors with MarketBeat's FREE daily newsletter.

VRX Stock News Headlines

Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
Despite Woes, Valeant May Be Headed for a Rebound
Valeant Pharmaceuticals International, Inc. (VRX)
Can Shopify break the curse of being number one?
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
See More Headlines
Receive VRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Valeant Pharmaceuticals International and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$10.76 billion
Optionable
Optionable
Beta
N/A

Key Executives

  • Mr. Joseph C. Papa (Age 63)
    CEO & Chairman
  • Mr. Paul S. Herendeen (Age 62)
    Exec. VP & CFO
  • Ms. Christina M. Ackermann (Age 53)
    Exec. VP & Gen. Counsel
  • Mr. Thomas J. Appio (Age 56)
    Exec. VP & Group Chairman of International
  • Mr. William D. Humphries (Age 52)
    Exec. VP & Group Chairman of Dermatology













VRX Stock - Frequently Asked Questions

How have VRX shares performed in 2023?

Valeant Pharmaceuticals International's stock was trading at C$30.80 on January 1st, 2023. Since then, VRX shares have increased by 0.0% and is now trading at C$30.80.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Valeant Pharmaceuticals International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Valeant Pharmaceuticals International investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Rogers Communications (RCI), Open Text (OTEX) and Toronto-Dominion Bank (TD).

What is Valeant Pharmaceuticals International's stock symbol?

Valeant Pharmaceuticals International trades on the Toronto Stock Exchange (TSX) under the ticker symbol "VRX."

How do I buy shares of Valeant Pharmaceuticals International?

Shares of VRX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Valeant Pharmaceuticals International's stock price today?

One share of VRX stock can currently be purchased for approximately C$30.80.

How much money does Valeant Pharmaceuticals International make?

Valeant Pharmaceuticals International (TSE:VRX) has a market capitalization of C$10.76 billion.

How can I contact Valeant Pharmaceuticals International?

Valeant Pharmaceuticals International's mailing address is 2150 Saint-Elzear Blvd W, LAVAL, QC H7L 4A8, Canada. The official website for the company is www.valeant.com. The specialty pharmaceutical company can be reached via phone at +1-514-7446792.

This page (TSE:VRX) was last updated on 1/31/2023 by MarketBeat.com Staff